Qinglin Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Qinglin Yang has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Ernest Ricks
Cardiovascular Research Institute, Morehouse School of Medicine, 720 Westview Dr. SW, Atlanta, GA 30310
1 shared publicationGuoliang Ding
Cardiovascular Research Institute, Morehouse School of Medicine, 720 Westview Dr. SW, Atlanta, GA 30310, USA
1 shared publicationJian Liu
Cardiovascular Research Institute, Morehouse School of Medicine, 720 Westview Dr. SW, Atlanta, GA 30310, USA
1 shared publication- Jianyi Zhang
Department of Biomedical Engineering, School of Medicine and School of Engineering, University of Alabama at Birmingham, Birmingham, AL 35294, USA
1 shared publication Jie Hou
Cardiovascular Research Institute, Morehouse School of Medicine, 720 Westview Dr. SW, Atlanta, GA 30310
1 shared publicationJoseph Lee
Department of Medicine, University of Minnesota Academic Health Center, Minneapolis, Minnesota 55455, USA
1 shared publication
Latest Publications
- 1 April 2007
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 74 (1) , 4-5
Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival
- 1 April 2007
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 74 (1) , 4-5
Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival
- 14 March 2007
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 85 (7) , 697-706
Roles of PPARs on regulating myocardial energy and lipid homeostasis
Myocardial energy and lipid homeostasis is crucial for normal cardiac structure and function. Either shortage of energy or excessive lipid accumulation in the heart leads to cardiac disorders. Peroxisome proliferator-activated receptors (PPARα, -β/δ and -γ), members of the nuclear receptor transcription factor superfamily, play important roles in regulating lipid metabolic genes. All three PPAR subtypes are expressed in cardiomyocytes. PPARα has been shown to control transcriptional expression of key enzymes that are involved in fatty acid (FA) uptake and oxidation, triglyceride synthesis, mitochondrial respiration uncoupling, and glucose metabolism. Similarly, PPARβ/δ is a transcriptional regulator of FA uptake and oxidation, mitochondrial respiration uncoupling, and glucose metabolism. On the other hand, the role of PPARγ on transcriptional regulation of FA metabolism in the heart remains obscure. Therefore, both PPARα and PPARβ/δ are important transcriptional regulators of myocardial energy and lipid homeostasis. Moreover, it appears that the heart needs to have two PPAR subtypes with seemingly overlapping functions in maintaining myocardial lipid and energy homeostasis. Further studies on the potential distinctive roles of each PPAR subtype in the heart should provide new therapeutic targets for treating heart disease.
- 14 March 2007
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 85 (7) , 697-706
Roles of PPARs on regulating myocardial energy and lipid homeostasis
Myocardial energy and lipid homeostasis is crucial for normal cardiac structure and function. Either shortage of energy or excessive lipid accumulation in the heart leads to cardiac disorders. Peroxisome proliferator-activated receptors (PPARα, -β/δ and -γ), members of the nuclear receptor transcription factor superfamily, play important roles in regulating lipid metabolic genes. All three PPAR subtypes are expressed in cardiomyocytes. PPARα has been shown to control transcriptional expression of key enzymes that are involved in fatty acid (FA) uptake and oxidation, triglyceride synthesis, mitochondrial respiration uncoupling, and glucose metabolism. Similarly, PPARβ/δ is a transcriptional regulator of FA uptake and oxidation, mitochondrial respiration uncoupling, and glucose metabolism. On the other hand, the role of PPARγ on transcriptional regulation of FA metabolism in the heart remains obscure. Therefore, both PPARα and PPARβ/δ are important transcriptional regulators of myocardial energy and lipid homeostasis. Moreover, it appears that the heart needs to have two PPAR subtypes with seemingly overlapping functions in maintaining myocardial lipid and energy homeostasis. Further studies on the potential distinctive roles of each PPAR subtype in the heart should provide new therapeutic targets for treating heart disease.
- Open Access
- 9 November 2006
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 24 (6) , 1269-1276
Open‐chest 31P magnetic resonance spectroscopy of mouse heart at 4.7 Tesla
Purpose: To develop a rapid, robust, and accurate method for assessing myocardial energetics in mice and demonstrate its applicability to mouse models of acquired and genetic heart disease.Materials and Methods: We combined surface coil localization (10‐mm diameter, tunable between 1H and 31P, using adiabatic half‐passage radiofrequency pulses) and surgery (electrocautery removal of anterior chest wall) to create an open‐chest method for acquiring in vivo 31P nuclear magnetic resonance (NMR) cardiac spectra from mice at 4.7T within 12 minutes. Normal BALB/c mice, BALB/c with myocardial infarction (MI), cardiomyocyte‐restricted peroxisome proliferator‐activated receptor‐delta knockout (KO) (CR‐PPARd–/–) and control loxP‐flanked Ppard (Ppardflox/flox) mice were examined.Results: The mean phosphocreatine (PCr)/adenosine triphosphate (ATP) ratios in control BALB/c mice, BALB/c MI mice, Ppardflox/flox mice, and PPAR‐δ KO mice were 2.13 ± 0.09 (N = 11), 1.35 ± 0.07 (N = 9, P < 0.001 vs. BALB/c control), 1.92 ± 0.09 (N = 5), and 1.31 ± 0.12 (N = 5, P < 0.005 vs. Ppardflox/flox control), respectively. The significant depression of myocardial PCr/ATP we observed in these genetic/acquired models of heart disease was in accord with previous data from analogous large animal models. No NMR signal contamination from chamber blood or adjacent skeletal muscle was identified.Conclusion: This new technique provides cardiac 31P spectra suitable for accurate quantitative analysis in a relatively short acquisition time, is suitable for terminal studies of mouse myocardial energy metabolism, and could be installed in virtually any NMR laboratory to study myocardial energetics in numerous mouse models of human heart disease. J. Magn. Reson. Imaging 2006.
- 9 November 2006
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 24 (6) , 1269-1276
Open AccessOpen‐chest 31P magnetic resonance spectroscopy of mouse heart at 4.7 Tesla
Purpose: To develop a rapid, robust, and accurate method for assessing myocardial energetics in mice and demonstrate its applicability to mouse models of acquired and genetic heart disease.Materials and Methods: We combined surface coil localization (10‐mm diameter, tunable between 1H and 31P, using adiabatic half‐passage radiofrequency pulses) and surgery (electrocautery removal of anterior chest wall) to create an open‐chest method for acquiring in vivo 31P nuclear magnetic resonance (NMR) cardiac spectra from mice at 4.7T within 12 minutes. Normal BALB/c mice, BALB/c with myocardial infarction (MI), cardiomyocyte‐restricted peroxisome proliferator‐activated receptor‐delta knockout (KO) (CR‐PPARd–/–) and control loxP‐flanked Ppard (Ppardflox/flox) mice were examined.Results: The mean phosphocreatine (PCr)/adenosine triphosphate (ATP) ratios in control BALB/c mice, BALB/c MI mice, Ppardflox/flox mice, and PPAR‐δ KO mice were 2.13 ± 0.09 (N = 11), 1.35 ± 0.07 (N = 9, P < 0.001 vs. BALB/c control), 1.92 ± 0.09 (N = 5), and 1.31 ± 0.12 (N = 5, P < 0.005 vs. Ppardflox/flox control), respectively. The significant depression of myocardial PCr/ATP we observed in these genetic/acquired models of heart disease was in accord with previous data from analogous large animal models. No NMR signal contamination from chamber blood or adjacent skeletal muscle was identified.Conclusion: This new technique provides cardiac 31P spectra suitable for accurate quantitative analysis in a relatively short acquisition time, is suitable for terminal studies of mouse myocardial energy metabolism, and could be installed in virtually any NMR laboratory to study myocardial energetics in numerous mouse models of human heart disease. J. Magn. Reson. Imaging 2006.